Main
>
ONCOLOGY (**)
>
Leukemia>Myeloid>Acute>CD33+***
>
Treatment
>
Co: USA. P. GemtuzuMAb Ozogamicin
>
(*) USA Approval Date: 2017. 09.01
(*) USA Approval Date: 2017. 09.01's products
This section has no products